IRP_USA_ALS Blog Post Image

On January 27, 2012, CMS published the much anticipated Proposed AMP Rule for implementing the Medicaid prescription drug provisions of the Patient Protection and Affordable Care Act (PPACA). The new guidelines will have a wide-reaching financial impact on the life sciences industry by creating serious administrative and operational challenges that will have to be addressed relatively quickly.